Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Clovis Oncology (CLVS)
NASDAQ:CLVS
Holding CLVS?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 06, 2022 | Gross Paul Edward Evp And General Counsel | xxxxxxxxxxxxx | $2770 |
| Sep 06, 2022 | Daniel Muehl Evp And Cfo | xxxxxxxxxxxxx | $2681 |
| Sep 06, 2022 | Gillian Ivers Read Evp Of Technical Operations And Chief Regulatory O | xxxxxxxxxxxxx | $2681 |
| Sep 06, 2022 | Harding Thomas C. Svp And Chief Scientific Officer | xxxxxxxxxxxxx | $1939 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2022 | xxxxxxxxxxxxx | $173026 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Clovis Oncology (CLVS)?
Currently, no data Available
What percentage of Clovis Oncology (CLVS) stock is held by institutional investors?
Currently, no data Available
What percentage of Clovis Oncology (CLVS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Clovis Oncology (CLVS)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.